HER2-Positive Breast Cancer: Biology, Clinical Presentation, and Targeted Therapies
1. Introduction to HER2-Positive Carcinomas HER2-positive breast carcinoma represents a highly specific and clinically significant molecular subtype of breast cancer, accounting for approximately twenty percent of all breast cancer diagnoses. This specific malignancy is defined by the profound overproduction of the Human Epidermal Growth Factor Receptor 2 protein on the surface of the tumor cells. … Read more